newsfilter
← Latest News
GlobeNewswire·

miRagen Therapeutics to Report Third Quarter 2019 Financial Results and Host a Conference Call

BOULDER, Colo., Oct. 22, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific...